1. Improving Cell Therapy Survival and Anabolism in Harsh Musculoskeletal Disease Environments
- Author
-
Niloofar Farhang, Robby D. Bowles, and Lara Silverman
- Subjects
medicine.medical_specialty ,Anabolism ,0206 medical engineering ,Cell ,Biomedical Engineering ,Cell- and Tissue-Based Therapy ,Bioengineering ,02 engineering and technology ,Osteoarthritis ,Bioinformatics ,Regenerative Medicine ,Biochemistry ,Regenerative medicine ,Biomaterials ,Cell therapy ,medicine ,Animals ,Humans ,Musculoskeletal Diseases ,business.industry ,Cell Differentiation ,Musculoskeletal disease ,021001 nanoscience & nanotechnology ,medicine.disease ,020601 biomedical engineering ,Clinical trial ,medicine.anatomical_structure ,Orthopedic surgery ,0210 nano-technology ,business - Abstract
Cell therapies are an up and coming technology in orthopedic medicine that has the potential to provide regenerative treatments for musculoskeletal disease. Despite numerous cell therapies showing preclinical success for common musculoskeletal indications of disc degeneration and osteoarthritis, there have been mixed results when testing these therapies in humans during clinical trials. A theory behind the mixed success of these cell therapies is that the harsh microenvironments of the disc and knee they are entering inhibit their anabolism and survival. Therefore, there is much ongoing research looking into how to improve the survival and anabolism of cell therapies within these musculoskeletal disease environments. This includes research into improving cell function under specific microenvironmental conditions known to exist in the intervertebral disc (IVD) and knee environment such as hypoxia, low-nutrient conditions, hyperosmolarity, acidity, and inflammation. This research also includes improving differentiation of cells into desired native cell phenotypes to better enhance their survival and anabolism in the knee and IVD. This review highlights the effects of specific musculoskeletal microenvironmental challenges on cell therapies and what research is being done to overcome these challenges. Impact statement While there has been significant clinical interest in using cell therapies for musculoskeletal pathologies in the knee and intervertebral disc, cell therapy clinical trials have had mixed outcomes. The information presented in this review includes the environmental challenges (i.e., acidic pH, inflammation, hyperosmolarity, hypoxia, and low nutrition) that cell therapies experience in these pathological musculoskeletal environments. This review summarizes studies that describe various approaches to improving the therapeutic capability of cell therapies in these harsh environments. The result is an overview of what approaches can be targeted and/or combined to develop a more consistent cell therapy for musculoskeletal pathologies.
- Published
- 2020